Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 28;91(8):2921–2938. doi: 10.1007/s00204-016-1918-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 2 — KI effects on activities of RCC I–V. Submitochondrial particles were incubated with KIs at 100-fold Cmax or the highest testable concentrations as. After 15 min, the activities of RCC I–V were measured. a, b, c, d, e Represents the activity of RCC I, II, III, IV, and V, respectively. The drugs in the X-axis were listed according to their approval date. The six KIs with a black box warning for hepatotoxicity were highlighted in a red box. The Y-axis represents the percentage of RCC activity after KI treatment as compared to DMSO-treated samples which were set as 100. Data are means and standard derivations from three independent experiments. *p < 0.05 as compared to DMSO-treated samples (color figure online)

Fig. 2 — KI effects on activities of RCC I–V. Submitochondrial particles were incubated with KIs at 100-fold Cmax or the highest testable concentrations as. After 15 min, the activities of RCC I–V were measured. a, b, c, d, e Represents the activity of RCC I, II, III, IV, and V, respectively. The drugs in the X-axis were listed according to their approval date. The six KIs with a black box warning for hepatotoxicity were highlighted in a red box. The Y-axis represents the percentage of RCC activity after KI treatment as compared to DMSO-treated samples which were set as 100. Data are means and standard derivations from three independent experiments. *p < 0.05 as compared to DMSO-treated samples (color figure online)